Diet and drug combo aim to tame tough tumors

NCT ID NCT05300048

First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 22 times

Summary

This study tested an experimental drug (serabelisib) combined with a low-insulin diet, with or without chemotherapy, in adults with advanced solid tumors that have specific genetic changes (PIK3CA mutations). The goal was to see if the diet could reduce side effects and improve the drug's ability to fight cancer. The study was terminated early, so results are limited.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Avera Cancer Institute

    Sioux Falls, South Dakota, 57105, United States

  • Baptist Hospitals of Southeast Texas

    Beaumont, Texas, 77701, United States

  • Community Health Network, Inc.

    Indianapolis, Indiana, 46250, United States

  • East Carolina University

    Greenville, North Carolina, 27858, United States

  • Englewood Health

    Englewood, New Jersey, 07631, United States

  • Hoag Memorial Hospital Presbyterian

    Newport Beach, California, 92663, United States

  • Lumi Research

    Kingwood, Texas, 77339, United States

  • Mayo Clinic - Rochester

    Rochester, Minnesota, 55902, United States

  • Medical College of Wisconsin

    Milwaukee, Wisconsin, 53226, United States

  • Memorial Sloan Kettering Cancer Center

    New York, New York, 10065, United States

  • New Jersey Cancer Care, PA

    Belleville, New Jersey, 07109, United States

  • Northwell Health

    Lake Success, New York, 11042, United States

  • Oncology Consultants, PA

    Houston, Texas, 77030, United States

  • Pacific Cancer Specialists

    Anaheim, California, 92801, United States

  • University of Alabama

    Birmingham, Alabama, 35429, United States

  • University of Pennsylvania Health System, Perelman Center for Advanced Medicine

    Philadelphia, Pennsylvania, 19104, United States

  • Valkyrie Clinical Trials

    Los Angeles, California, 90067, United States

Conditions

Explore the condition pages connected to this study.